Table2.
Characteristics of participants by categories of MetS status at baseline and follow-up
| Variables | Non-MetS (n = 176) |
Incident MetS (n = 35) |
Recovery MetS (n = 41) |
Persistent MetS (n = 88) |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Follow-up | P | Baseline | Follow-up | P | Baseline | Follow-up | P | Baseline | Follow-up | P | |
| WC | 81.24 ± 8.83 | 86.49 ± 9.38 | <0.001 | 86.4 ± 11.68 | 97.61 ± 8.91 | <0.001 | 91.25 ± 10.61 | 93.27 ± 11.86 | 0.167 | 97.66 ± 7.93 | 101.8 ± 8.41 | <0.001 |
| BMI | 25 ± 3.86 | 26.41 ± 3.63 | <0.001 | 26.47 ± 4.37 | 29.47 ± 4.27 | <0.001 | 27.42 ± 4.29 | 27.36 ± 4.67 | 0.881 | 30.17 ± 4.43 | 30.99 ± 4.4 | <0.001 |
| FBS | 87 (81,92) | 88 (83,92) | 0.173 | 87 (79,96) | 94 (86,107) | 0.002 | 89 (83,100) | 92 (86.5,97) | 0.141 | 99.5 (89,111) | 100.5 (91,119) | 0.283 |
| SBP | 111 (104,119) | 110 (102,120) | 0.110 | 115 (111,127) | 123 (115,132) | 0.015 | 121 (114,135) | 114 (104.5126.5) | 0.001 | 128.5 (115.5143.75) | 126 (116.25,138.75) | 0.161 |
| DBP | 73.82 ± 8.52 | 70.54 ± 8.15 | <0.001 | 76.26 ± 5.34 | 74.66 ± 7.83 | 0.226 | 81.81 ± 11.15 | 73.46 ± 9.28 | <0.001 | 83.64 ± 10.68 | 77.03 ± 9.36 | <0.001 |
| TG | 104 (77.25,146.75) | 105 (78.75,138.75) | 0.364 | 135 (102,177) | 170 (112,209) | 0.037 | 180 (161.5228) | 128 (107,179) | <0.001 | 210.5 (151.25,266.75) | 191.5 (142.5259) | 0.015 |
| HDL-C | 42 (39,49) | 43 (36.25,49) | 0.160 | 42 (35,53) | 39 (32,46) | 0.002 | 39 (35,49) | 43 (37,47.5) | 0.056 | 39 (32,46) | 38 (33,43) | 0.786 |
| AdipoQ | 13.24 (6.59,25.13) | 12.11 (5.77,22.8) | 0.004 | 12.48 (7.06,19.19) | 9.32 (5.67,15) | 0.010 | 10.78 (7.34,21.15) | 11.04 (6.32,19.17) | 0.056 | 11.87 (6.32,21.83) | 11.84 (5.75,21.35) | 0.980 |
| Hcy | 11.62 (7.72,18.09) | 11.34 (7.73,17.19) | 0.716 | 9.48 (7.15,19.14) | 10.48 (7.64,16.13) | 0.166 | 12.01 (7.88,23.47) | 12.24 (7.86,20.24) | 0.957 | 12.04 (8.15,18.29) | 12.26 (7.74,19.75) | 0.779 |
| hs-CRP | 0.86 (0.35,1.97) | 0.85 (0.42,2.04) | 0.335 | 0.74 (0.42,1.77) | 1.9 (0.68,3.21) | <0.001 | 1.7 (0.91,2.73) | 1.39 (0.51,3.16) | 0.510 | 1.18 (0.74,3.47) | 1.97 (0.93,3.43) | 0.083 |
| IL-6 | 3.98 (1.83,10.73) | 2.08 (1.01,4.6) | <0.001 | 5.48 (2.16,10.62) | 3.57 (2.42,7.5) | 0.256 | 6.02 (2.12,19.09) | 4.02 (1.37,7.61) | 0.006 | 4.59 (2.08,11.95) | 3.87 (1.76,8.21) | 0.067 |
| IL-10 | 4.46 (2.58,7.57) | 3.87 (2.43,6.58) | 0.001 | 3.96 (1.97,8.22) | 4.19 (1.97,6.32) | 0.158 | 4.28 (2.6,7.76) | 4.69 (2.02,7.75) | 0.706 | 4.38 (2.43,7.74) | 4.22 (2.11,6.48) | 0.037 |
Abbreviations: MetS, metabolic syndrome; BMI, body mass index; WC, waist circumference; FBS fasting blood sugar; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; HDL-C, high-density lipoprotein; AdipoQ, adiponectin; Hcy, homocysteine; hs-CRP, high-sensitivity C-reactive protein; IL-6, interleukin-6; IL-10, interleukin-10.
Data are n (%), median (IQR), or mean±SD.
The p-values are for the paired t-test (normal variables) and Wilcoxon signed-rank test (skewed variables).